Interstitial lung disease and CDK4/6 inhibitors in the treatment of breast cancer

Overview of attention for article published in Expert Opinion on Drug Safety, November 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 50 X posts from 46 X users, with an upper bound of 101,841 followers.

RT @DFCI_BreastOnc: 📄Special Report just published by Drs. Ilana Schlam (@IlanaSchlam), Antonio Giordano (@antgiorda) & Sara Tolaney (@stol…

RT @DFCI_BreastOnc: 📄Special Report just published by Drs. Ilana Schlam (@IlanaSchlam), Antonio Giordano (@antgiorda) & Sara Tolaney (@stol…

RT @DFCI_BreastOnc: 📄Special Report just published by Drs. Ilana Schlam (@IlanaSchlam), Antonio Giordano (@antgiorda) & Sara Tolaney (@stol…

RT @DFCI_BreastOnc: 📄Special Report just published by Drs. Ilana Schlam (@IlanaSchlam), Antonio Giordano (@antgiorda) & Sara Tolaney (@stol…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 46 additional X posts.